Intrinsic value of MetLife - MET

Previous Close

$45.10

  Intrinsic Value

$0.00

stock screener

  Rating & Target

str. sell

-100%

Previous close

$45.10

 
Intrinsic value

$0.00

 
Up/down potential

-100%

 
Rating

str. sell

Our model is not good at valuating stocks of financial companies, such as MET.

We calculate the intrinsic value of MET stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 47.4

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.50
  2.75
  2.97
  3.18
  3.36
  3.52
  3.67
  3.80
  3.92
  4.03
  4.13
  4.22
  4.29
  4.36
  4.43
  4.49
  4.54
  4.58
  4.62
  4.66
  4.70
  4.73
  4.75
  4.78
  4.80
  4.82
  4.84
  4.85
  4.87
  4.88
Revenue, $m
  63,866
  65,622
  67,574
  69,721
  72,064
  74,603
  77,342
  80,285
  83,435
  86,798
  90,382
  94,192
  98,236
  102,524
  107,064
  111,866
  116,941
  122,300
  127,956
  133,922
  140,211
  146,838
  153,819
  161,169
  168,906
  177,048
  185,614
  194,625
  204,102
  214,066
Variable operating expenses, $m
  59,331
  60,892
  62,627
  64,535
  66,617
  68,873
  71,308
  73,922
  76,722
  79,711
  80,324
  83,710
  87,304
  91,115
  95,149
  99,417
  103,927
  108,690
  113,717
  119,019
  124,608
  130,497
  136,701
  143,233
  150,109
  157,345
  164,958
  172,967
  181,389
  190,244
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  59,331
  60,892
  62,627
  64,535
  66,617
  68,873
  71,308
  73,922
  76,722
  79,711
  80,324
  83,710
  87,304
  91,115
  95,149
  99,417
  103,927
  108,690
  113,717
  119,019
  124,608
  130,497
  136,701
  143,233
  150,109
  157,345
  164,958
  172,967
  181,389
  190,244
Operating income, $m
  4,535
  4,730
  4,948
  5,187
  5,447
  5,730
  6,035
  6,362
  6,713
  7,087
  10,058
  10,482
  10,932
  11,409
  11,914
  12,449
  13,014
  13,610
  14,239
  14,903
  15,603
  16,341
  17,117
  17,935
  18,796
  19,703
  20,656
  21,659
  22,713
  23,822
EBITDA, $m
  92,706
  95,256
  98,090
  101,206
  104,607
  108,293
  112,269
  116,540
  121,113
  125,995
  131,197
  136,727
  142,598
  148,822
  155,412
  162,382
  169,749
  177,529
  185,739
  194,399
  203,528
  213,148
  223,280
  233,950
  245,181
  257,000
  269,435
  282,515
  296,271
  310,735
Interest expense (income), $m
  1,202
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
  23,980
Earnings before tax, $m
  -19,445
  -19,249
  -19,032
  -18,793
  -18,532
  -18,250
  -17,945
  -17,618
  -17,267
  -16,893
  -13,922
  -13,498
  -13,048
  -12,570
  -12,065
  -11,531
  -10,966
  -10,370
  -9,740
  -9,076
  -8,376
  -7,639
  -6,862
  -6,044
  -5,183
  -4,277
  -3,324
  -2,321
  -1,266
  -158
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -19,445
  -19,249
  -19,032
  -18,793
  -18,532
  -18,250
  -17,945
  -17,618
  -17,267
  -16,893
  -13,922
  -13,498
  -13,048
  -12,570
  -12,065
  -11,531
  -10,966
  -10,370
  -9,740
  -9,076
  -8,376
  -7,639
  -6,862
  -6,044
  -5,183
  -4,277
  -3,324
  -2,321
  -1,266
  -158

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Adjusted assets (=assets-cash), $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Revenue / Adjusted assets
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
Average production assets, $m
  855,992
  879,532
  905,698
  934,476
  965,872
  999,908
  1,036,618
  1,076,054
  1,118,276
  1,163,359
  1,211,386
  1,262,452
  1,316,661
  1,374,127
  1,434,974
  1,499,337
  1,567,358
  1,639,191
  1,714,999
  1,794,958
  1,879,250
  1,968,072
  2,061,630
  2,160,144
  2,263,843
  2,372,972
  2,487,788
  2,608,561
  2,735,576
  2,869,133
Working capital, $m
  -667,716
  -686,078
  -706,489
  -728,938
  -753,428
  -779,977
  -808,613
  -839,375
  -872,311
  -907,477
  -944,941
  -984,775
  -1,027,060
  -1,071,886
  -1,119,350
  -1,169,556
  -1,222,616
  -1,278,649
  -1,337,784
  -1,400,155
  -1,465,907
  -1,535,193
  -1,608,173
  -1,685,018
  -1,765,909
  -1,851,035
  -1,940,597
  -2,034,806
  -2,133,884
  -2,238,065
Total debt, $m
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
  444,067
Total liabilities, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total equity, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total liabilities and equity, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Debt-to-equity ratio
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
Adjusted equity ratio
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -19,445
  -19,249
  -19,032
  -18,793
  -18,532
  -18,250
  -17,945
  -17,618
  -17,267
  -16,893
  -13,922
  -13,498
  -13,048
  -12,570
  -12,065
  -11,531
  -10,966
  -10,370
  -9,740
  -9,076
  -8,376
  -7,639
  -6,862
  -6,044
  -5,183
  -4,277
  -3,324
  -2,321
  -1,266
  -158
Depreciation, amort., depletion, $m
  88,171
  90,525
  93,142
  96,020
  99,160
  102,563
  106,234
  110,178
  114,400
  118,908
  121,139
  126,245
  131,666
  137,413
  143,497
  149,934
  156,736
  163,919
  171,500
  179,496
  187,925
  196,807
  206,163
  216,014
  226,384
  237,297
  248,779
  260,856
  273,558
  286,913
Funds from operations, $m
  68,727
  71,276
  74,110
  77,227
  80,627
  84,313
  88,289
  92,560
  97,133
  102,016
  107,217
  112,748
  118,619
  124,842
  131,432
  138,403
  145,770
  153,549
  161,760
  170,419
  179,549
  189,168
  199,301
  209,970
  221,201
  233,020
  245,455
  258,535
  272,291
  286,756
Change in working capital, $m
  -16,286
  -18,362
  -20,411
  -22,449
  -24,490
  -26,549
  -28,636
  -30,762
  -32,936
  -35,167
  -37,463
  -39,834
  -42,285
  -44,826
  -47,464
  -50,206
  -53,060
  -56,033
  -59,135
  -62,371
  -65,752
  -69,285
  -72,980
  -76,845
  -80,891
  -85,126
  -89,562
  -94,209
  -99,078
  -104,181
Cash from operations, $m
  85,013
  89,638
  94,521
  99,676
  105,118
  110,862
  116,925
  123,322
  130,069
  137,182
  144,680
  152,581
  160,904
  169,669
  178,896
  188,609
  198,830
  209,583
  220,894
  232,791
  245,301
  258,454
  272,281
  286,816
  302,092
  318,146
  335,017
  352,744
  371,369
  390,937
Maintenance CAPEX, $m
  -83,513
  -85,599
  -87,953
  -90,570
  -93,448
  -96,587
  -99,991
  -103,662
  -107,605
  -111,828
  -116,336
  -121,139
  -126,245
  -131,666
  -137,413
  -143,497
  -149,934
  -156,736
  -163,919
  -171,500
  -179,496
  -187,925
  -196,807
  -206,163
  -216,014
  -226,384
  -237,297
  -248,779
  -260,856
  -273,558
New CAPEX, $m
  -20,866
  -23,540
  -26,166
  -28,779
  -31,396
  -34,035
  -36,711
  -39,436
  -42,223
  -45,083
  -48,027
  -51,066
  -54,209
  -57,466
  -60,847
  -64,362
  -68,021
  -71,833
  -75,809
  -79,958
  -84,292
  -88,822
  -93,558
  -98,513
  -103,700
  -109,129
  -114,816
  -120,773
  -127,015
  -133,558
Cash from investing activities, $m
  -104,379
  -109,139
  -114,119
  -119,349
  -124,844
  -130,622
  -136,702
  -143,098
  -149,828
  -156,911
  -164,363
  -172,205
  -180,454
  -189,132
  -198,260
  -207,859
  -217,955
  -228,569
  -239,728
  -251,458
  -263,788
  -276,747
  -290,365
  -304,676
  -319,714
  -335,513
  -352,113
  -369,552
  -387,871
  -407,116
Free cash flow, $m
  -19,366
  -19,501
  -19,598
  -19,673
  -19,726
  -19,760
  -19,776
  -19,776
  -19,759
  -19,728
  -19,682
  -19,623
  -19,550
  -19,463
  -19,364
  -19,251
  -19,125
  -18,986
  -18,833
  -18,667
  -18,487
  -18,293
  -18,085
  -17,861
  -17,622
  -17,367
  -17,096
  -16,808
  -16,502
  -16,178
Issuance/(repayment) of debt, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total cash flow (excl. dividends), $m
  -19,366
  -19,501
  -19,598
  -19,673
  -19,726
  -19,760
  -19,776
  -19,776
  -19,759
  -19,728
  -19,682
  -19,623
  -19,550
  -19,463
  -19,364
  -19,251
  -19,125
  -18,986
  -18,833
  -18,667
  -18,487
  -18,293
  -18,085
  -17,861
  -17,622
  -17,367
  -17,096
  -16,808
  -16,502
  -16,178
Retained Cash Flow (-), $m
  -19,445
  -19,249
  -19,032
  -18,793
  -18,532
  -18,250
  -17,945
  -17,618
  -17,267
  -16,893
  -13,922
  -13,498
  -13,048
  -12,570
  -12,065
  -11,531
  -10,966
  -10,370
  -9,740
  -9,076
  -8,376
  -7,639
  -6,862
  -6,044
  -5,183
  -4,277
  -3,324
  -2,321
  -1,266
  -158
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -19,445
  -19,249
  -19,032
  -18,793
  -18,532
  -18,250
  -17,945
  -17,618
  -17,267
  -16,893
  -13,922
  -13,498
  -13,048
  -12,570
  -12,065
  -11,531
  -10,966
  -10,370
  -9,740
  -9,076
  -8,376
  -7,639
  -6,862
  -6,044
  -5,183
  -4,277
  -3,324
  -2,321
  -1,266
  -158
Discount rate, %
  15.80
  16.59
  17.42
  18.29
  19.20
  20.17
  21.17
  22.23
  23.34
  24.51
  25.74
  27.02
  28.37
  29.79
  31.28
  32.85
  34.49
  36.21
  38.02
  39.93
  41.92
  44.02
  46.22
  48.53
  50.96
  53.50
  56.18
  58.99
  61.94
  65.03
PV of cash for distribution, $m
  -16,792
  -14,161
  -11,756
  -9,598
  -7,699
  -6,062
  -4,678
  -3,536
  -2,613
  -1,886
  -1,121
  -765
  -507
  -326
  -203
  -123
  -71
  -40
  -21
  -11
  -5
  -2
  -1
  0
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

MetLife, Inc. is a provider of life insurance, annuities, employee benefits and asset management. The Company's segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses. Its Asia segment offers products, including life insurance; accident and health insurance, and retirement and savings products. Latin America offers products, including life insurance, and retirement and savings products. Life insurance includes universal, variable and term life products. EMEA offers products, including life insurance, accident and health insurance, retirement and savings products, and credit insurance.

FINANCIAL RATIOS  of  MetLife (MET)

Valuation Ratios
P/E Ratio 61.8
Price to Sales 0.8
Price to Book 0.7
Price to Tangible Book
Price to Cash Flow 3.3
Price to Free Cash Flow 3.7
Growth Rates
Sales Growth Rate -9.2%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 16.7%
Cap. Spend. - 3 Yr. Gr. Rate -4.2%
Financial Strength
Quick Ratio 0
Current Ratio NaN
LT Debt to Equity 29.1%
Total Debt to Equity 29.5%
Interest Coverage 1
Management Effectiveness
Return On Assets -0.5%
Ret/ On Assets - 3 Yr. Avg. 0.3%
Return On Total Capital 0.9%
Ret/ On T. Cap. - 3 Yr. Avg. 4.7%
Return On Equity 1.2%
Return On Equity - 3 Yr. Avg. 6.1%
Asset Turnover 0.1
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 2.6%
EBITDA Margin - 3 Yr. Avg. 10.2%
Operating Margin 1.6%
Oper. Margin - 3 Yr. Avg. 9.2%
Pre-Tax Margin -0.3%
Pre-Tax Margin - 3 Yr. Avg. 7.5%
Net Profit Margin 1.3%
Net Profit Margin - 3 Yr. Avg. 5.8%
Effective Tax Rate 512.3%
Eff/ Tax Rate - 3 Yr. Avg. 189.7%
Payout Ratio 229.9%

MET stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the MET stock intrinsic value calculation we used $62308 million for the last fiscal year's total revenue generated by MetLife. The default revenue input number comes from 2017 income statement of MetLife. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our MET stock valuation model: a) initial revenue growth rate of 2.5% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 15.8%, whose default value for MET is calculated based on our internal credit rating of MetLife, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of MetLife.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of MET stock the variable cost ratio is equal to 93%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for MET stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for MetLife.

Corporate tax rate of 27% is the nominal tax rate for MetLife. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the MET stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for MET are equal to 1340.3%.

Life of production assets of 10 years is the average useful life of capital assets used in MetLife operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for MET is equal to -1045.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $0 million for MetLife - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 1052 million for MetLife is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of MetLife at the current share price and the inputted number of shares is $47.4 billion.

RELATED COMPANIES Price Int.Val. Rating

COMPANY NEWS

▶ Insurance ETFs Looking Good Post Q2 Earnings   [Aug-08-18 11:20AM  Zacks]
▶ MetLife, Inc. to Host Earnings Call   [07:00AM  ACCESSWIRE]
▶ [$$] Old Long-Term-Care Policies Hurt Prudential Profit   [Aug-01-18 10:50PM  The Wall Street Journal]
▶ MetLife: 2Q Earnings Snapshot   [05:27PM  Associated Press]
▶ Whats in the Cards for MetLife (MET) Stock in Q2 Earnings?   [Jul-30-18 03:10PM  InvestorPlace]
▶ [$$] Insurers Pull Billions From Hedge Funds   [Jul-25-18 12:08PM  The Wall Street Journal]
▶ [$$] Insurers Pull Billions From Hedge Funds   [Jul-24-18 08:05PM  The Wall Street Journal]
▶ MetLife launches new startup accelerator in Cary   [08:15AM  American City Business Journals]
▶ MetLife Names Ed Spehar as Treasurer   [Jul-09-18 04:15PM  Business Wire]
▶ MetLife Declares Third Quarter 2018 Common Stock Dividend   [Jul-06-18 04:15PM  Business Wire]
▶ MetLife wrongly presumed hundreds of pensioners were dead, Galvin says   [Jun-25-18 02:45PM  American City Business Journals]
▶ Look to Aegon Stock for Dividends, but Not for Growth   [Jun-20-18 10:27AM  InvestorPlace]
▶ [$$] How Computers Could Make Your Customer-Service Calls More Human   [Jun-16-18 10:30AM  The Wall Street Journal]
▶ Top Ranked Income Stocks to Buy for June 15th   [Jun-15-18 10:13AM  Zacks]
▶ MetLife and Insurtech Start-Ups Ignite Innovation   [Jun-14-18 07:00AM  Business Wire]
▶ 7 Valuable Low Price-to-Sales Stocks to Garner Good Profits   [May-25-18 01:20PM  InvestorPlace]
▶ Changes coming to One Beacon, one of Boston's largest office towers   [11:28AM  American City Business Journals]
▶ Facebook signs San Francisco's biggest office lease deal ever   [09:48AM  American City Business Journals]
▶ MetLife names Bill O'Donnell as U.S. CFO   [May-16-18 04:28PM  Reuters]
▶ Q1 Earnings Fail to Drive Insurance ETFs   [May-11-18 11:40AM  Zacks]
▶ 7 Low Price-to-Sales Stocks to Buy for Spectacular Returns   [May-10-18 12:10PM  InvestorPlace]
▶ Is MetLife Inc (NYSE:MET) Undervalued?   [May-09-18 07:39PM  Simply Wall St.]
▶ MetLife unveils design of its new 'Midtown Union' project   [12:38PM  American City Business Journals]
▶ FedEx to transfer $6B in pension plan obligations to MetLife   [09:09AM  American City Business Journals]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.